TJX
51
-3
AN
57
5
FLS
63
-6
EQIX
64
-5
GOOG
67
4
DVN
25
4
STX
64
-2
CNX
83
4
BA
39
3
MHK
56
3
GIS
49
6
AES
58
3
NI
67
4
CI
65
3
TXT
60
4
ZBH
53
-3
V
42
4
SJM
48
2
MDLZ
53
-4
CAT
70
-2
TJX
51
-3
AN
57
5
FLS
63
-6
EQIX
64
-5
GOOG
67
4
DVN
25
4
STX
64
-2
CNX
83
4
BA
39
3
MHK
56
3
GIS
49
6
AES
58
3
NI
67
4
CI
65
3
TXT
60
4
ZBH
53
-3
V
42
4
SJM
48
2
MDLZ
53
-4
CAT
70
-2
Financhill
Back

Penumbra Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
64

PEN
Penumbra

Last Price:
191.56
Seasonality Move:
-0.27%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
64
Penumbra (PEN) is a Buy

Is Penumbra a Buy, Sell or Hold?

  • The current Penumbra [PEN] share price is $191.55. The Score for PEN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • PEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PEN Stock Price Chart

What is Penumbra's stock price today?

  • The Penumbra share price today is $191.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PEN is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 47.94 Sell
Chaikin Money Flow: -39409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (191.32 - 204.42) Sell
Bollinger Bands (100): (178.73 - 201.29) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

PEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 193.47 Sell
20-day SMA: 196.43 Sell
50-day SMA: 189.82 Buy
200-day SMA: 214.08 Sell
8-day EMA: 192.33 Sell
20-day EMA: 193.88 Sell
50-day EMA: 192.58 Sell
200-day EMA: 207.84 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Penumbra Earnings Growth & PEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.27 per share, an increase this year of $0.56 per share, and an increase next year of $0.97 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Penumbra Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):